149 related articles for article (PubMed ID: 8167117)
1. What are the implications of cardiac infection with cytomegalovirus before heart transplantation?
Lowry RW; Adam E; Hu C; Kleiman NS; Cocanougher B; Windsor N; Bitar JN; Melnick JL; Young JB
J Heart Lung Transplant; 1994; 13(1 Pt 1):122-8. PubMed ID: 8167117
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
3. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
Lam KM; Oldenburg N; Khan MA; Gaylore V; Mikhail GW; Strouhal PD; Middeldorp JM; Banner N; Yacoub M
J Heart Lung Transplant; 1998 Jun; 17(6):555-65. PubMed ID: 9662090
[TBL] [Abstract][Full Text] [Related]
4. Histologic and molecular diagnosis of myocardial human cytomegalovirus infection after heart transplantation.
Pucci A; Ghisetti V; Donegani E; Barbui A; David E; Fortunato M; Papandrea C; Pansini S; Zattera G; di Summa M
J Heart Lung Transplant; 1994; 13(6):1072-80. PubMed ID: 7865514
[TBL] [Abstract][Full Text] [Related]
5. [Identification of DNA of cytomegalovirus, its antibodies and viral antigens in patients after organ transplantation].
Dolgikh MS; Vediakov AM; Feoktistova EIu; Adueva SM; Makarova NE; Kushch AA; Pustovoĭt B
Biull Eksp Biol Med; 1999 May; 127(5):560-3. PubMed ID: 10399583
[No Abstract] [Full Text] [Related]
6. Cytomegalovirus detection in lung transplant biopsy samples by polymerase chain reaction.
Flint A; Frank TS
J Heart Lung Transplant; 1994; 13(1 Pt 1):38-42. PubMed ID: 8167125
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplants.
Arbustini E; Grasso M; Diegoli M; Percivalle E; Grossi P; Bramerio M; Campana C; Goggi C; Gavazzi A; Vigano M
Am J Clin Pathol; 1992 Aug; 98(2):205-13. PubMed ID: 1324600
[TBL] [Abstract][Full Text] [Related]
8. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
[TBL] [Abstract][Full Text] [Related]
9. [Clinical course of cytomegalovirus infection in renal transplant recipients].
Luchsinger V; Suárez M; Montiel F; Kaltwasser G
Rev Med Chil; 1999 Jan; 127(1):9-17. PubMed ID: 10436673
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
11. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus and acute rejection after heart transplantation are not directly associated.
Boriskin YS; Booth JC; Corbishley CM; Madden BP; McKenna WJ; Murday AJ; Steel HM
J Med Virol; 1996 Sep; 50(1):59-70. PubMed ID: 8890042
[TBL] [Abstract][Full Text] [Related]
13. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of cytomegalovirus infection following human heart-lung transplantation.
Burke CM; Glanville AR; Macoviak JA; O'Connell BM; Tazelaar HD; Baldwin JC; Jamieson SW; Theodore J
J Heart Transplant; 1986; 5(4):267-72. PubMed ID: 3040942
[TBL] [Abstract][Full Text] [Related]
15. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
[TBL] [Abstract][Full Text] [Related]
16. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
Koskinen PK; Krogerus LA; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
J Heart Lung Transplant; 1993; 12(3):343-54. PubMed ID: 8392371
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
[TBL] [Abstract][Full Text] [Related]
20. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
